340 related articles for article (PubMed ID: 3795531)
41. Simple liquid-chromatographic measurement of vanillylmandelic acid and homovanillic acid in urine on filter paper for mass screening of neuroblastoma in infants.
Hanai J; Kawai T; Sato Y; Takasugi N; Nishi M; Takeda T
Clin Chem; 1987 Nov; 33(11):2043-6. PubMed ID: 3677377
[TBL] [Abstract][Full Text] [Related]
42. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.
Nakagawara A; Zaizen Y; Ikeda K; Suita S; Ohgami H; Nagahara N; Sera Y; Akiyama H; Kawakami K; Uchino J
Cancer; 1991 Nov; 68(9):2037-44. PubMed ID: 1913552
[TBL] [Abstract][Full Text] [Related]
43. Natural course of neuroblastoma detected by mass screening: s 5-year prospective study at a single institution.
Nishihira H; Toyoda Y; Tanaka Y; Ijiri R; Aida N; Takeuchi M; Ohnuma K; Kigasawa H; Kato K; Nishi T
J Clin Oncol; 2000 Aug; 18(16):3012-7. PubMed ID: 10944135
[TBL] [Abstract][Full Text] [Related]
44. Mass screening and age-specific incidence of neuroblastoma in Saitama Prefecture, Japan.
Yamamoto K; Hayashi Y; Hanada R; Kikuchi A; Ichikawa M; Tanimura M; Yoshioka S
J Clin Oncol; 1995 Aug; 13(8):2033-8. PubMed ID: 7636545
[TBL] [Abstract][Full Text] [Related]
45. Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment.
Okazaki T; Kohno S; Mimaya J; Hasegawa S; Urushihara N; Yoshida A; Kawano S; Kusafuka J; Horikoshi Y; Takashima Y; Aoki K; Hamazaki M
Pediatr Surg Int; 2004 Jan; 20(1):27-32. PubMed ID: 14689211
[TBL] [Abstract][Full Text] [Related]
46. HPLC-ED determination of catecholamines and their metabolites in urine.
Brandsteterová E; Kubalec P; Skacáni I; Balazovjech I
Neoplasma; 1994; 41(4):205-11. PubMed ID: 7935993
[TBL] [Abstract][Full Text] [Related]
47. A new urinary mass screening system for neuroblastoma in infancy by use of monoclonal antibodies against VMA and HVA.
Yokomori K; Hori T; Tsuchida Y; Kuroda M; Yoshioka M
J Pediatr Surg; 1989 Apr; 24(4):391-4. PubMed ID: 2659761
[TBL] [Abstract][Full Text] [Related]
48. The relationship between homovanillic/vanillylmandelic acid ratios and prognosis in neuroblastoma.
Nishi M; Miyake H; Takeda T; Hanai J; Fujita K; Ichimiya H; Tanaka T; Hirama T; Ishikawa Y; Kudoh T; Azuma H; Takase A
Oncol Rep; 1998; 5(3):631-3. PubMed ID: 9538165
[TBL] [Abstract][Full Text] [Related]
49. Para-O-methylation of the catecholamines in neuroblastoma.
Verheyden R; Ebinger G
Clin Chim Acta; 1975 Jan; 58(2):181-4. PubMed ID: 1122641
[TBL] [Abstract][Full Text] [Related]
50. Screening for neuroblastoma in the north of England.
Parker L; Craft AW; Dale G; Bell S; Cole M; McGill AC; Seviour JA; Smith J
BMJ; 1992 Nov; 305(6864):1260-3. PubMed ID: 1303649
[TBL] [Abstract][Full Text] [Related]
51. Comparative study of vanillylmandelic acid in random and 24-hour urine collections.
Riddhimat R; Prabhant C; Sirisali K; Tangvarasithichai O; Poosiri A
J Med Assoc Thai; 1990 May; 73(5):239-43. PubMed ID: 2212910
[TBL] [Abstract][Full Text] [Related]
52. Neuroblastoma screening in the United States: results of the Texas Outreach Program for neuroblastoma screening.
Ater JL; Gardner KL; Foxhall LE; Therrell BL; Bleyer WA
Cancer; 1998 Apr; 82(8):1593-602. PubMed ID: 9554539
[TBL] [Abstract][Full Text] [Related]
53. [Bacterial contamination of infant urine samples obtained from filter papers used in neuroblastoma-screening tests. (6) Protective effects of preaddition of chlorhexidine digluconate in filter papers or containers for urine on bacterial break-down of creatinine, vanillylmandelic acid and homovanillic acid].
Imai J; Iwata H; Gotoh K; Mori H; Kawai M
Nihon Koshu Eisei Zasshi; 1992 Oct; 39(10):789-98. PubMed ID: 1467545
[TBL] [Abstract][Full Text] [Related]
54. "Total" acidic metabolites of catecholamines in urine as determined by hydrolysis with hydriodic acid and liquid chromatography: application to patients with neuroblastoma and melanoma.
Ito S; Kato T; Maruta K; Jimbow K; Fujita K
Clin Chem; 1985 Jul; 31(7):1185-8. PubMed ID: 4006189
[TBL] [Abstract][Full Text] [Related]
55. Urinary creatinine adjusted reference ranges for homovanillic and vanillylmandelic acid in children and adults.
Cole M; Craft AW; Parker L; Bell S; Seviour JA; McGill AC; Dale G
Clin Chim Acta; 1995 Apr; 236(1):19-32. PubMed ID: 7664463
[TBL] [Abstract][Full Text] [Related]
56. Urinary VMA, dopamine and the likelihood of neuroblastoma: a preferred way of reporting laboratory results?
Sies CW; Florkowski CM; Sullivan M; Mackay R; George PM
Ann Clin Biochem; 2006 Jul; 43(Pt 4):300-5. PubMed ID: 16824281
[TBL] [Abstract][Full Text] [Related]
57. Measurement of urinary vanillylmandelic acid (VMA) and homovanillic acid (HVA) for diagnosis of neural crest tumors.
Sawada T
Pediatr Hematol Oncol; 1997; 14(4):291-3. PubMed ID: 9211532
[No Abstract] [Full Text] [Related]
58. Screening for neuroblastoma in North America. 2-year results from the Quebec Project.
Woods WG; Tuchman M; Bernstein ML; Leclerc JM; Brisson L; Look T; Brodeur GM; Shimada H; Hann HL; Robison LL
Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):312-9. PubMed ID: 1456396
[TBL] [Abstract][Full Text] [Related]
59. Vanilmandelic acid and homovanillic acid levels in patients with neural crest tumor: 24-hour urine collection versus random sample.
Gregianin LJ; McGill AC; Pinheiro CM; Brunetto AL
Pediatr Hematol Oncol; 1997; 14(3):259-65. PubMed ID: 9185210
[TBL] [Abstract][Full Text] [Related]
60. A trial to discriminate spontaneous regression from non-regression cases during mass screening for neuroblastoma.
Nishi M; Miyake H; Takeda T; Yonemori H; Hanai J; Kikuchi Y; Takasugi N
Jpn J Clin Oncol; 1994 Oct; 24(5):247-51. PubMed ID: 7967103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
